In Spring 2019, the LT Murray Family Foundation, a charitable organization based in Washington state that primarily supports programs in the Puget Sound area, made a generous contribution to The Geneva Foundation (Geneva) in support of the first small grant competition for researchers at Joint Base Lewis-McChord (JBLM). Throughout April, Geneva received ten competitive applications
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced that, for the first time, the U.S. Food and Drug Administration (FDA) has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus (EBOV) infections. This agreement was made possible
The Uniformed Services University (USU) recently issued a Cooperative Agreement to The Geneva Foundation (Geneva) for $2.2M to investigate the efficacy of antimicrobial Blue light therapies (aBL) at combating infections at the implant site for osseointegrated (OI) implant technology. This program was funded by Defense Health Agency (DHA) with partnerships from USU, Geneva, The Wellman
The Uniformed Services University of the Health Sciences (USU) recently issued a cooperative agreement to The Geneva Foundation (Geneva) to facilitate the execution of the Collaboratory for Musculoskeletal Injury Rehabilitation Research (CMIRR). CMIRR is a four-year, $15M program funded by the Defense Health Agency (DHA), with the purpose of improving our rehabilitative approach to caring
Jonas Nursing and Veterans Healthcare and The Geneva Foundation have announced the recipients of a joint scholarship – two doctoral nursing candidates seeking to improve healthcare for veterans and military personnel. This marks the second time since 2016 that the organizations have partnered to award scholarships in support of their shared causes. Ph.D. candidates Lisa
Exxell BIO, with offices in St. Paul and Rochester, Minnesota, is part of a new consortium formed to prepare and test a vaccine formulation designed to protect against the Ebola, Sudan, Marburg, and Lassa fever viruses. Exxell BIO worked with Thomas Jefferson University (TJU) in the development of a TJU-led consortium for this major vaccine
As the Chief of Viral Immunology within the Virology Division at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Dr. John M. Dye, Jr. oversees the execution of research programs in medical countermeasures against viral biological warfare agents in a high-hazard, multi-suite, bio-containment laboratory that operates at Biosafety Levels 2, 3, and
Dr. Luis Alvarez is the founding Principal Investigator of the Regenerative Biology Research Group at the U.S. National Cancer Institute. He also serves as an Academy Professor and Director of the Center for Molecular Science in the Department of Chemistry and Life Science at the United States Military Academy at West Point. Previously, Dr. Alvarez